Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Lilly patents novel farnesoid X receptor agonists for the treatment of lipoprotein disorders

Feb. 25, 2009

Solvay reports a novel sildenafil prodrug for erectile dysfunction in recent patent

Feb. 25, 2009

Acrux reports positive data for contraceptive skin spray trials

Feb. 23, 2009

Conbriza receives positive CHMP opinion for osteoporosis

Feb. 20, 2009

Plethora Solutions and Sciele Pharma provide clinical update on PSD-502 for premature ejaculation

Feb. 19, 2009

FDA accepts Amgen's submission and files denosumab BLA for PMO and bone loss

Feb. 19, 2009

Diamyd receives approval for phase III study of Diamyd in nine European countries

Feb. 19, 2009

Bayer discloses novel GSK-3beta inhibitors for hematological disorders

Feb. 19, 2009

Phase II clinical trial commences for Merck & Co./Arena niacin receptor agonist

Feb. 19, 2009

GSK initiates phase III program for novel type 2 diabetes drug, Syncria

Feb. 18, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...